Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting symbols : Nktr save search
Nektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting
Published: 2023-12-11 (Crawled : 23:00) - prnewswire.com
NKTR | News | $1.415 4.04% 3.89% 1.1M
|
Health Technology
|
| O: 1.63%
H: 0.0%
C: -7.45%
nktr-255 presentation preclinical meeting
Nektar Announces Poster Presentations at the 64th American Society of Hematology (ASH) Annual Meeting
Published: 2022-12-12 (Crawled : 15:20) - prnewswire.com
NKTR | News | $1.415 4.04% 3.89% 1.1M
|
Health Technology
|
| O: -1.79%
H: 2.18%
C: -1.45%
meeting
Nektar Therapeutics Presents Preclinical Data from Novel PEGylated Interferon Gamma Program, NKTR-288, at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2022-11-10 (Crawled : 16:00) - biospace.com/
NKTR | News | $1.415 4.04% 3.89% 1.1M
|
Health Technology
|
| O: 2.23%
H: 7.24%
C: 6.28%
nktr-288 preclinical immunotherapy meeting therapeutics cancer
Poxel to Present DESTINY-1 Phase 2 Results for PXL065 in NASH at AASLD The Liver Meeting® 2022 POXEL SA announced that its late-breaking abstract describing the results from its Phase 2 study of PXL065...
Published: 2022-10-12 (Crawled : 07:00) - biospace.com/
NKTR | News | $1.415 4.04% 3.89% 1.1M
|
Health Technology
|
| O: -1.69%
H: 3.29%
C: 0.57%
pxl065 meeting liver nash study phase 2
Nektar and Collaborators Present Preclinical Data on NKTR-255, a Novel IL-15 Receptor Agonist, in combination with CAR Cell Therapies at the 2022 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR®
Published: 2022-04-23 (Crawled : 00:20) - prnewswire.com
NKTR | News | $1.415 4.04% 3.89% 1.1M
|
Health Technology
| Email alert
Add to watchlist
nktr-255 cibmtr preclinical therapy pre-clinical
Nykode Therapeutics announces presentation of preclinical data from its second generation Vaccibody vaccine technology at 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
NKTR | News | $1.415 4.04% 3.89% 1.1M
|
Health Technology
|
| O: 0.17%
H: 1.21%
C: -4.67%
research preclinical vaccine technology therapeutics presentation cancer pre-clinical
Nykode Therapeutics to Present at 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
NKTR | News | $1.415 4.04% 3.89% 1.1M
|
Health Technology
|
| O: 5.13%
H: 4.78%
C: 1.66%
america research therapeutics cancer
Lilly Highlights Innovation-based Growth Strategy and Pipeline Developments; Announces 2022 Financial Guidance at Investment Community Meeting
Published: 2021-12-15 (Crawled : 15:30) - biospace.com/
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 4.7%
H: 0.0%
C: 0.0%
RIGL | $1.135 0.44% 0.44% 520K
|
Health Technology
|
| O: 0.42%
H: 5.91%
C: 5.06%
PRQR | News | $2.04 2.0% 1.96% 180K
|
Health Technology
|
| O: 0.61%
H: 0.0%
C: 0.0%
NKTR | News | $1.415 4.04% 3.89% 1.1M
|
Health Technology
|
| O: 0.16%
H: 2.52%
C: 2.05%
MRUS | $40.75 0.74% 0.74% 570K
|
Health Technology
|
| O: -0.71%
H: 9.28%
C: 9.24%
FHTX | $5.135 1.68% 1.66% 46K
|
Health Technology
|
| O: -1.75%
H: 9.43%
C: 1.03%
growth
Nektar Therapeutics Presents Clinical Data for NKTR-255 in Patients with Relapsed/Refractory Hematologic Malignancies, Including Patients with Prior CAR-T Therapy, at the 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-12-13 (Crawled : 14:30) - biospace.com/
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 1.27%
H: 0.0%
C: 0.0%
NKTR | News | $1.415 4.04% 3.89% 1.1M
|
Health Technology
|
| O: -3.33%
H: 0.0%
C: 0.0%
nktr-255 ema car-t therapeutics therapy
Nektar Therapeutics Announces Data Presentations for its Immuno-Oncology Programs at the European Society for Medical Oncology Immuno-Oncology (ESMO-IO) Congress 2021 and the 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-11-30 (Crawled : 14:00) - biospace.com/
NKTR | News | $1.415 4.04% 3.89% 1.1M
|
Health Technology
|
| O: -2.3%
H: 0.0%
C: 0.0%
ema europe therapeutics presentation
Nektar Therapeutics Announces Data Presentations for Its Immuno-Oncology Pipeline at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2021-11-12 (Crawled : 12:00) - prnewswire.com
NKTR | News | $1.415 4.04% 3.89% 1.1M
|
Health Technology
|
| O: 2.01%
H: 0.0%
C: 0.0%
presentation immunotherapy therapy cancer
Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors with Cancer Specialist During 2021 Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-11-09 (Crawled : 15:15) - biospace.com/
NKTR | News | $1.415 4.04% 3.89% 1.1M
|
Health Technology
|
| O: -0.96%
H: 1.24%
C: -4.76%
immunotherapy therapy cancer conference
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.